PBH
Prestige Consumer HealthcareDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Composite grade D from latest DB weights. Momentum 16.0 / Value 69.1
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
16
Value
69
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $66.00
Why
Momentum16 · Δ7d +2.0
Value69 · Δ7d -0.2
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
16
40% active weight
Current posture
7d trendImproving
Δ7d
+2.0
Δ21d
+0.7
Value
69
60% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 16.0 / Value 69.1
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$2.39B
Beta
0.43
Shares Out
47.37M
P/E (TTM)
15.5
P/S (TTM)
2.71
P/FCF (TTM)
11.76
Rev YoY
-5.0%
EPS YoY
+12.9%
Gross Margin
+52.8%
Op Margin
+29.9%
Net Debt
$981.56M
Current Ratio
3.57
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology